5-chloro-3-phenyl-6,7-dihydropyrrolo[3,4-g]indol-8(1H)-one

ID: ALA5290575

Max Phase: Preclinical

Molecular Formula: C16H11ClN2O

Molecular Weight: 282.73

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1NCc2c(Cl)cc3c(-c4ccccc4)c[nH]c3c21

Standard InChI:  InChI=1S/C16H11ClN2O/c17-13-6-10-11(9-4-2-1-3-5-9)7-18-15(10)14-12(13)8-19-16(14)20/h1-7,18H,8H2,(H,19,20)

Standard InChI Key:  IWKDQQIVXBSVBE-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 20 23  0  0  0  0  0  0  0  0999 V2000
   -1.7567   -0.0325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0421    0.3797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3301   -0.0320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3301   -0.8573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0403   -1.2690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7567   -0.8610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2814    0.5175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8704    1.1840    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0523    1.2690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5446    0.2234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5446   -1.1170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0315   -0.4467    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0759    0.3045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6578    0.8861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4498    0.6731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6628   -0.1216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0851   -0.7015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2898   -0.4933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7574    1.0179    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0371   -2.0941    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  3  7  1  0
  2  8  1  0
  8  9  1  0
  9  7  2  0
  1 10  1  0
  6 11  1  0
 11 12  1  0
 12 10  1  0
 13  7  1  0
 14 13  2  0
 15 14  1  0
 16 15  2  0
 17 16  1  0
 13 18  1  0
 18 17  2  0
 10 19  2  0
  5 20  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5290575

    ---

Associated Targets(Human)

CLK3 Tchem Dual specificity protein kinase CLK3 (2711 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CLK1 Tchem Dual specificty protein kinase CLK1 (2189 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CLK2 Tchem Dual specificity protein kinase CLK2 (3942 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 282.73Molecular Weight (Monoisotopic): 282.0560AlogP: 3.73#Rotatable Bonds: 1
Polar Surface Area: 44.89Molecular Species: NEUTRALHBA: 1HBD: 2
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.14CX Basic pKa: CX LogP: 3.15CX LogD: 3.15
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.70Np Likeness Score: 0.08

References

1. Qin Z, Qin L, Feng X, Li Z, Bian J..  (2021)  Development of Cdc2-like Kinase 2 Inhibitors: Achievements and Future Directions.,  64  (18.0): [PMID:34519506] [10.1021/acs.jmedchem.1c00985]

Source